RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Clinical trials for RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New hope pill tested for tough blood cancers

Disease control Ongoing

This early-stage study is testing a new oral medication called AUTX-703 for adults with advanced forms of blood cancer (AML or MDS) that have returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body handles the drug. Researcher…

Matched conditions: RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Phase: PHASE1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

Get alerted when new RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) trials appear

New hope pill tested for tough blood cancers